Tillmann TAUBE,Gerd Michael MUNZERT,Dorothea Ingrid RUDOLPH
申请号：
US15147037
公开号：
US20160243124A1
申请日:
2016.05.05
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the use of BI 6727 or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising the administration of a high dose of BI 6727 according to a specific dosage schedule, optionally in combination with cytarabine.
